BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $2.17M in the quarter ending June 30, 2024, with 32.11% growth. This brings the company's revenue in the last twelve months to $219.12M, up 3,761.22% year-over-year. In the year 2023, BridgeBio Pharma had annual revenue of $9.30M, down -88.02%.

• Revenue (ttm): $219.12M
• Revenue Growth: +3,761.22%
• P/S Ratio: 20.59
• Revenue / Employee: $394,108
• Employees: 556
• Market Cap: 4.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.30M	-68.35M	-88.02%
Dec 31, 2022	77.65M	7.93M	11.38%
Dec 31, 2021	69.72M	61.47M	745.14%
Dec 31, 2020	8.25M	-32.31M	-79.66%
Dec 31, 2019	40.56M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.